MEANS FOR CHRONIC ATROPHIC GASTRITIS TREATMENT Russian patent published in 2017 - IPC A61K31/15 A61P1/04 

FIELD: pharmacology.

SUBSTANCE: means for chronic atrophic gastritis treatment represents β-alanilamid betulonic acid of formula (I)

.

The result is achieved by restoration of the pool of cells producing gastric juice and hydrochloric acid, and recovery of the number of acid mucin secreting cells to the baseline.

EFFECT: means effectively reduces the symptoms of chronic atrophic gastritis, reduces the CAG inflammatory component severity, no epithelial cells desquamation and veins expansion, infiltration of own gastric mucosa plate with cellular elements decreases significantly mainly by reducing the number of lymphocytes and monocytes, macrophages, restores the gastric mucosa, wherein an increase in the glands size and a decrease in the distance between them, decreased expression of sclerotic changes signs, acquisition of more highly specialized structure of epithelium glands.

17 dwg, 3 tbl